Invivyd (IVVD) Operating Expenses (2021 - 2025)
Invivyd (IVVD) posted Operating Expenses of $29.8 million for Q4 2025, up 23.23% on a QoQ basis from $24.2 million in Q3 2025, and down 9.95% year-over-year from $33.0 million in Q4 2024.
Invivyd (IVVD) Operating Expenses (2021 - 2025) Analysis & Trends
Invivyd's Operating Expenses history runs 5 years deep, the most recent figure standing at $29.8 million for Q4 2025.
- Quarterly Operating Expenses fell 9.95% year-over-year to $29.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $109.0 million (down 46.12% YoY) and the FY2025 annual result came in at $109.0 million, down 46.12% from the prior year.
- Operating Expenses was $29.8 million for Q4 2025 at Invivyd, up from $24.2 million in the prior quarter.
- Across five years, Operating Expenses topped out at $100.7 million in Q1 2022 and bottomed at $24.2 million in Q3 2025.
- A 5-year average of $49.9 million and a median of $46.7 million in 2022 frame the typical range for Operating Expenses.
- Annual changes were most pronounced in 2022 — Operating Expenses soared 160.25% — and 2025, when it sank 66.27%.
- Invivyd's Operating Expenses stood at $83.1 million in 2021, then slumped by 41.98% to $48.2 million in 2022, then jumped by 59.2% to $76.8 million in 2023, then slumped by 56.94% to $33.0 million in 2024, then fell by 9.95% to $29.8 million in 2025.
- Business Quant data shows IVVD's Operating Expenses at $29.8 million in Q4 2025, $24.2 million in Q3 2025, and $26.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | -28.01 Mn |
| 2 | Nanobiotix | 1,935.05 Bn | 1,934.98 Bn | - | - |
| 3 | Akari Therapeutics | 1,045.06 Bn | 1,045.06 Bn | - | 15.76 Mn |
| 4 | BeOne Medicines | 468.98 Bn | 464.19 Bn | 1.35 Bn | 1.10 Bn |
| 5 | Vertex Pharmaceuticals | 123.24 Bn | 115.99 Bn | 2.59 Bn | 1.85 Bn |
| 6 | Regeneron Pharmaceuticals | 70.45 Bn | 61.70 Bn | 3.31 Bn | 2.96 Bn |
| 7 | Belite Bio | 63.04 Bn | 63.04 Bn | - | 32.68 Mn |
| 8 | Argenx Se | 55.79 Bn | 50.60 Bn | 1.41 Bn | 2.89 Bn |
| 9 | Alnylam Pharmaceuticals | 37.79 Bn | 34.78 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Invivyd | 103.53 Mn | -123.15 Mn | 16.07 Mn | 29.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 29.76 Mn |
| Sep 30, 2025 | 24.15 Mn |
| Jun 30, 2025 | 26.85 Mn |
| Mar 31, 2025 | 28.23 Mn |
| Dec 31, 2024 | 33.05 Mn |
| Sep 30, 2024 | 71.61 Mn |
| Jun 30, 2024 | 51.51 Mn |
| Mar 31, 2024 | 46.09 Mn |
| Dec 31, 2023 | 76.75 Mn |
| Sep 30, 2023 | 43.06 Mn |
| Jun 30, 2023 | 53.88 Mn |
| Mar 31, 2023 | 39.07 Mn |
| Dec 31, 2022 | 48.21 Mn |
| Sep 30, 2022 | 47.33 Mn |
| Jun 30, 2022 | 51.75 Mn |
| Mar 31, 2022 | 100.74 Mn |
| Dec 31, 2021 | 83.09 Mn |
| Sep 30, 2021 | 60.42 Mn |
| Jun 30, 2021 | 44.69 Mn |
| Mar 31, 2021 | 38.71 Mn |